NEWS / BLOG
Gentronix News and Blog section gives you our latest company updates, comments on the field of toxicology and insights into our business, values and commitment to our clients.
LATEST NEWS
Gentronix Ltd appoints experienced CRO executive as its new non-executive Chairman
Following the retirement of previous Chairman, John Nicholson, at the end of 2019, the Gentronix Board of Directors welcomes Alan Morgan as non-executive Chairman. Alan joins the Gentr [...]
Gentronix Ltd set to double in size following Northern VCT investment
Gentronix Ltd, a contract research business based at Alderley Park, is planning to double in size following a £750,000 investment from the Northern Venture Capital Trust Funds (VCTs), [...]
Gentronix will be at Eurotox 2019
Gentronix is looking forward to meeting you at Eurotox 2019 in Helsinki in September (7th-11th). Our Managing Director, Matt Tate, and our skin sensitisation expert, Marie Cumberbatch [...]
BLOG
Introduction to our Direct Peptide Reactivity Assay (DPRA) Service
Within the skin sensitisation adverse outcome pathway, the first key event is based on the premise that a chemical can become a skin sensitiser via interaction with skin proteins, form [...]
New Service: OECD 439 Reconstructed Human Epidermis Skin Irritation Test
As part of the continuing growth and expansion of services at Gentronix, we are pleased to announce the establishment and certified laboratory proficiency for the OECD 439 Reconstructe [...]
A Brief Guide to our in vitro Skin Sensitisation Services
Our in vitro skin sensitisation services focus on safety assessments of our client’s materials against the adverse outcome pathway for the human skin sensitisation response. Using mini [...]
OUR VALUES
OUR VALUES
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
LATEST VACANCIES
At Gentronix, we have a passion for the science of toxicology. Building on our experience gained from the pharmaceutical, agrochemical and CRO industries, we are committed to engaging with our clients to deliver the highest quality to science to support their projects. If believe you have the toxicology knowledge and the interest to support us in delivering this commitment, we’re interested to learn more.